Culture-Associated Changes in the Human Cardiac Fibroblast Surfaceome: A Proteomic Resource for Cell Surface Marker and Target Discovery
Roneldine MesidoriD, Linda Berg LueckeiD, Matthew WaasiD, Jennifer Schneider, Garam ParkiD, Ella RoweiD, Kyu Shik KimiD, Heather C Jensen-SmithiD, Erin N SchuetteiD, Pranav RenavikariD, Claudius MahriD, Daniel R AndersoniD, Rebekah L GundryiD
Abstract
Cardiac fibroblasts (CF) are central to cardiac homeostasis and fibrosis, but the lack of reliable cell surface markers limits their direct isolation, characterization, and selective targeting in human myocardium. Most CF studies use cultured cells, yet how the cell surface changes during culture remains poorly defined. We used mass spectrometry-based surfaceome profiling in five sequential substudies of human CF, spanning failing and non-failing hearts, fresh and cryopreserved myocardium, and laboratory-isolated and commercially sourced cells. Culture was associated with extensive changes in surface protein abundance, which were largest between P0 and P1 and were reproduced in CF from fresh and cryopreserved tissue. These changes included increases in proteins associated with fibroblast activation and matrix production, and changes in proteins used as CF markers and pharmacologic targets. Whole cell proteomics showed that these changes extended beyond the cell surface. Because culture history shapes cultured CF, we examined 30 years of CF literature, revealing widespread use of later, mixed, or unreported passages and incomplete reporting of culture conditions. To aid future studies, we developed CFxplorer (CFxplorer.net), an interactive resource that integrates this literature analysis, passage-resolved protein trajectories, and a Human CF Surfaceome Atlas of 1,577 cell surface N-glycoproteins detected across 234 CF samples, with extracellular peptide evidence and biological and pharmacologic annotations to help prioritize candidate surface markers and targets for validation. Collectively, this study expands the human CF surfaceome, defines how it changes during culture, and shows that the properties of cultured CF should be verified, not assumed, before use in experiments.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Defining the cardiac fibroblast secretome in the healthy and infarcted mouse heart
Jasmin Bahr, Gereon Poschmann, … Jürgen Schrader·Communications BiologyPeer-reviewed·Apr 29, 2025
- Identification of CD4+ Sub-population of Resident Cardiac Fibroblasts Linked to Myocardial Fibrosis
J. H. Siamwala, F. Pagano, … R. J. Gilbert·bioRxiv·Feb 26, 2021
- Mechanical history shapes phenotypic plasticity and fibroblast-autonomous 3D remodeling in iPSC-derived cardiac fibroblasts
Huanzhu Jiang, Ganesh Malayath, … Nathaniel Huebsch·bioRxiv·Oct 25, 2026
- Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure
J. M. Amrute, X. Luo, … K. Lavine·bioRxiv·Oct 17, 2022
- Dysferlin is a novel regulator of COMP-positive matrifibrocytes in heart failure
Ievgeniia Kocherova, Muriel Giger, … Gabriela Kania·bioRxiv·Aug 21, 2026
- Modeling cardiac fibroblast heterogeneity from human pluripotent stem cell-derived epicardial cells
Ian M. Fernandes, Shunsuke Funakoshi, … Gordon M. Keller·Nature CommunicationsPeer-reviewed·Dec 11, 2023